Refine by
Hospital Acquired Infections Articles & Analysis
84 news found
A Centers for Disease Control and Prevention (CDC) report published on October 3, 2024, linked Burkholderia multivorans infections to ice machines in multiple healthcare facilities in the western United States. This post summarizes key findings, implications, and recommended practices for healthcare providers to ensure patient ...
The IAQ Video Network and Cochrane & Associates announced the release of their latest educational video today. Their newest production discusses vancomycin-resistant enterococci, commonly referred to as VRE, which are bacteria that can cause various healthcare-associated infections (HAIs). “In the CDC’s 2019 Antibiotic Resistance Threats in the United States report, VRE was ...
Fortunately, most healthy people breathe Aspergillus spores without infection concerns. However, some species are known to be a serious infection risk for individuals with comorbidities such as weakened immune systems or lung disease. ...
The Centers for Disease Control and Prevention describe Acinetobacter as a group of bacteria commonly found in the environment in places like soil and water. While there are many types, the most frequent cause of infections in humans is known as Acinetobacter baumannii. Those most at risk of infection according to the CDC include patients in hospitals, especially those who: · are ...
Acinetobacter is described by the Centers for Disease Control and Prevention (CDC) as a group of bacteria commonly found in the environment in places like soil and water. While there are many types, the most frequent cause of infections in humans is known as Acinetobacter baumannii. Infections of the blood, urinary tract and lungs, or in wounds in other parts of the body can all be caused by ...
Fortunately, most healthy people breathe Aspergillus spores without infection concerns. However, some species are known to be a serious infection risk for individuals with weakened immune systems or lung disease. Of the approximately 180 species of Aspergillus, fewer than 40 of them are known to cause infections in humans according to the Centers ...
A single MRSA post-surgical infection costs over $160,000 to treat and adds 15 days onto a hospital stay. In parallel, Destiny Pharma is considering two additional indications for XF-73 Nasal in oncology patients and in community acquired infections. These extra Phase 3 studies would provide supportive data and life cycle ...
Particular support for decolonisation of pathogens which is the approach taken by its XF-73 Nasal programme Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, today reports on the publication of findings from the US Food and Drug Administration (FDA) and ...
This broad-spectrum approach targets the primary source of infection as well as bacterial cofactors that may also contribute to substantial comorbidity. Nasal photodisinfection has been deployed over the past decade in Canadian hospitals to significantly reduce hospital-acquired infections. Ondine’s ...
These high-quality testing solutions cover infectious and transmissible disease areas – including respiratory, sexually transmitted infections, hospital acquired infections, and women’s health – and are designed to revolutionise turnaround times for results in almost any setting, bringing cost and time savings ...
Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi Ondine’s nonantibiotic photodisinfection technology has been proven in Canadian hospitals to kill pathogens helping to generate 84% reduction of postoperative infection ...
Fouling of endotracheal tubes is associated with an increased risk of respiratory complications, increased antibiotic usage, infection and longer stays in the ICU. The clinical studies received the requisite ethics approvals from Health Canada and Western IRB prior to commencement in December 2018. ...
RP-L201 well-tolerated with durable CD18 expression for all patients in Phase 2 pivotal trial 100% overall survival in patients at one year after RP-L201 infusion based on Kaplan-Meier estimate All patients showed clinical reversal of disease course, including statistically significant reduction in all-cause hospitalizations and incidence of severe infections Initiating discussions with ...
Dr. Roisin Molloy, CEO, and co-founder of TriMedika; an innovative medical technology manufacturer, supplying the most accurate hospital-grade non-contact thermometers to hospitals worldwide, based in Belfast. Innovate UK launched Women in Innovation in 2016, after research revealed that just 1 in 7 applications for Innovate UK support came from women. Boosting the number of female entrepreneurs ...
A July 2019 White House executive order on kidney care (the Advancing American Kidney Health Initiative) proposed that 80% of new patients with end-stage renal disease (ESRD) be treated with either kidney transplantation or home dialysis by 2025, a significant increase from current rates, which are below 20%. “End-stage renal disease, one of the costliest chronic diseases in the U.S., is ...
Further fueling the demand is the rise in hospital acquired infections (HAIs) that globally cause more fatalities due to the increase in antibiotic resistance from even simple infections. ...
Further fueling the demand is the rise in hospital acquired infections (HAIs) that globally cause more fatalities due to the increase in antibiotic resistance from even simple infections. ...
Department of Health and Human Services (HHS), to prioritize a quality measure for hospitals and healthcare systems to achieve a blood culture contamination of one percent or less. ...
Visby Medical™, a leading medical diagnostic company, today announced results from the cross-sectional single visit patient outcomes and implementation study, which evaluated self-collected vaginal swab samples from 55 women using the Visby Medical Sexual Health Click Test for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV). The results of this ...
Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination for sepsis testing,1 today announced that six studies, reporting zero or near-zero blood culture contamination rates and up to a 31% reduction in vancomycin days of therapy (DOT) using Steripath, were submitted, accepted and published in ...